Skip to main content
. 2021 Mar 4;11:22. doi: 10.1186/s13550-021-00762-1

Table 1.

Patient characteristics and outcome from 6 [99mTc]Tc-PSMA-I&S RGS lymphadenectomies

No Age at surgery (years) PSA at surgery (ng/ml) Gleason score at primary stage Activity 99mTc-PSMA (MBq) LN/LNM removed overall (n) LNM detected (n) Removed non nodal** PCa-tissue (n) Anatomical subregions at LA (n) Manually separated “single-samples” (n)
Number of patients (extended lymph node dissections) overall n = 6
 1 69 2.27 4 + 3 680 79 15 18 78
 2 49 128 5 + 4 660 135 42 1 12 84
 3 63 67.63 4 + 4 692 123 8 15 126
 4 68 0.99 4 + 4 537 36 2 8 56
 5 65 11.78 4 + 4 674 50 8 12 58
 6 52 54.82 4 + 3 584 93 85 10 8 96
 Sum 516 160 11 73 498
Origin of tissue specimens from 73 subregions: n/73 (%)
Right common iliac 7/73 (10%) Left common iliac 6/73 (8%) Aortic bifurcation 1/73 (1%)
Right external iliac 6/73 (8%) Left external iliac 7/73 (10%) Interaortocaval 3/73 (4%)
Right obturator iliac 4/73 (6%) Left obturator iliac 4/73 (6%) Paraaortal 4/73 (5%)
Right internal iliac 7/73 (10%) Left internal iliac 5/73 (8%) Miscellaneous* 9/73 (11%)
Right presacral region 6/73 (8%) Left presacral region 4/73 (5%)

LNM lymph node metastases, LN lymph node, PSA prostate specific antigen, LA lymphadenectomy, PCa prostate cancer

*miscellaneous regions: mesorectal, pillar of urinary bladder, region of the musculus piriformis, retroduodenal, renal hilum, ductus deferens

**non-nodal PCa-tissue: residuals of seminal vesicle (n = 7), and deferent duct (n = 3) and solid PCa-tissue in the of left fossa obturatoria (n = 1)